-
Info
-
Comments
BASF SE agreed to buy Pronova BioPharma ASA in a transaction valuing the Norwegian company at 3.76 billion kroner ($654 million) to gain a leading position in Omega-3 fatty acids used in drugs and health foods.
BASF to Pay $654 Million for Pronova
Advertisement
BTV Channel Finder
ZIP is required for U.S. locations
Bloomberg Television in change
Rate this Page